Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/26
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years.The Motley Fool • 03/21/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum TranscriptSeeking Alpha • 03/21/26
Recursion Pharmaceuticals (RXRX) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 03/19/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/06/26
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue EstimatesZacks Investment Research • 02/25/26
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock UpZacks Investment Research • 02/25/26
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 02/25/26
What's in Store for These 5 Medical Companies This Earnings Season?Zacks Investment Research • 02/23/26
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25GlobeNewsWire • 02/18/26
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 02/04/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference TranscriptSeeking Alpha • 01/22/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26